HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shigeki Moriguchi Selected Research

DM 235

10/2013Novel nootropic drug sunifiram enhances hippocampal synaptic efficacy via glycine-binding site of N-methyl-D-aspartate receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shigeki Moriguchi Research Topics

Disease

15Alzheimer Disease (Alzheimer's Disease)
07/2022 - 10/2003
7Ischemia
10/2009 - 09/2005
5Brain Ischemia (Cerebral Ischemia)
10/2009 - 09/2005
4Memory Disorders (Memory Loss)
01/2020 - 07/2008
3Learning Disabilities (Learning Disability)
01/2018 - 04/2006
3Dementia (Dementias)
01/2017 - 10/2003
3Cognitive Dysfunction
01/2017 - 04/2011
3Embolism (Embolus)
01/2008 - 09/2005
2Neurodegenerative Diseases (Neurodegenerative Disease)
07/2022 - 10/2013
2Bipolar Disorder (Manic Depressive Psychosis)
10/2009 - 09/2006
2Hypertrophy
01/2009 - 12/2007
2Myocardial Ischemia (Ischemic Heart Diseases)
01/2008 - 10/2007
2Infarction (Infarctions)
01/2008 - 01/2006
1Anxiety Disorders (Anxiety Disorder)
01/2018
1Autism Spectrum Disorder
10/2016
1Inflammation (Inflammations)
10/2016
1Neoplasms (Cancer)
03/2015
1Autistic Disorder (Autism)
01/2014
1X-Linked Mental Retardation (Mental Retardation, X Linked)
06/2011
1ATR-X syndrome
06/2011
1Thalassemia
06/2011
1Schizophrenia (Dementia Praecox)
10/2009
1Mental Disorders (Mental Disorder)
10/2009
1Myocardial Infarction
01/2008
1Reperfusion Injury
10/2007
1Rhabdomyosarcoma
09/2007
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
07/2006

Drug/Important Bio-Agent (IBA)

10Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2020 - 04/2006
6Cholinergic Agents (Cholinergics)IBA
03/2014 - 10/2003
5Proteins (Proteins, Gene)FDA Link
05/2018 - 09/2005
5N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2017 - 12/2003
4Nootropic Agents (Nootropics)IBA
10/2013 - 10/2003
3N-Methylaspartate (NMDA)IBA
10/2009 - 10/2005
3Tyrosine (L-Tyrosine)FDA Link
01/2008 - 09/2005
3Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
01/2008 - 09/2006
3CalcineurinIBA
12/2007 - 07/2006
33- (2- (4- (3- chloro- 2- methylphenyl)1- piperazinyl)ethyl)5,6- dimethoxy- 1- (4- imidazolylmethyl)- 1H- indazol dihydrochloride 3.5 hydrateIBA
12/2007 - 09/2005
2Donepezil (Aricept)FDA LinkGeneric
01/2017 - 10/2005
2Pyrrolidinones (Pyrrolidones)IBA
10/2013 - 10/2003
2spiro(imidazo- (1,2- a)pyridine- 3,2- indan)- 2(3H)- oneIBA
04/2011 - 07/2008
2Calcium-Calmodulin-Dependent Protein KinasesIBA
10/2009 - 09/2006
23- (2- (4- (3- chloro- 2- methylphenyl)- 1- piperazinyl)ethyl)- 5,6- dimethoxyindazoleIBA
01/2009 - 12/2007
2Fas Ligand Protein (Fas Ligand)IBA
10/2007 - 09/2007
2CalpainIBA
09/2007 - 07/2006
2Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
02/2007 - 10/2005
2nefiracetamIBA
12/2003 - 10/2003
1Propolis (Bee Bread)IBA
07/2022
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2020
1protein kinase modulatorIBA
01/2020
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
01/2020
1KN 93IBA
01/2020
1N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA
01/2020
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2020
1zeta-inhibitory peptideIBA
01/2020
1U 0126 (UO 126)IBA
01/2020
1Messenger RNA (mRNA)IBA
05/2018
1CalciumIBA
05/2018
1CorticosteroneIBA
01/2018
1Cholinesterase Inhibitors (Anticholinesterases)IBA
01/2017
1Memantine (Namenda)FDA Link
01/2017
1GTP-Binding Proteins (G-Protein)IBA
10/2016
1LigandsIBA
10/2016
1Protein Kinases (Protein Kinase)IBA
10/2016
1Rivastigmine (Exelon)FDA LinkGeneric
03/2014
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2014
1MelatoninIBA
01/2014
1Piracetam (Nootropil)IBA
10/2013
1DM 235IBA
10/2013
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
02/2012
1Sigma-1 ReceptorIBA
06/2011
1Dehydroepiandrosterone (DHEA)IBA
06/2011
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
06/2011
1Adenosine Triphosphate (ATP)IBA
06/2011
1Protein Kinase CIBA
06/2011
1nobiletinIBA
10/2009
1Antipsychotic Agents (Antipsychotics)IBA
10/2009
1Serotonin (5 Hydroxytryptamine)IBA
10/2009
1CytokinesIBA
10/2009
1Nerve Growth Factors (Neurotrophins)IBA
10/2009
1Dopamine (Intropin)FDA LinkGeneric
10/2009
1ErbB Receptors (EGF Receptor)IBA
10/2009
1Heparin-binding EGF-like Growth Factor (HB-EGF)IBA
10/2009
1indanIBA
07/2008
1pyridineIBA
07/2008
1Glutamic Acid (Glutamate)FDA Link
01/2008
1CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA
01/2008
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2008
1vanadyl sulfateIBA
01/2008
1DystrophinIBA
12/2007
1Phenylephrine (Neo-Synephrine)FDA LinkGeneric
12/2007
1Angiotensin IIIBA
12/2007
1Endothelin-1 (Endothelin 1)IBA
12/2007
1phospholambanIBA
12/2007
1Tacrolimus (Prograf)FDA LinkGeneric
09/2007
1Forkhead Transcription Factors (Forkhead Box Proteins)IBA
09/2007
1LithiumIBA
09/2006

Therapy/Procedure

3Therapeutics
04/2011 - 09/2006
3Microspheres (Microsphere)
01/2008 - 09/2005
1Aftercare (After-Treatment)
03/2015
1Oral Administration
07/2008